A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants
Clinical trial NCT03618160 · TERMINATED
Trial details
- NCT number
- NCT03618160
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2019-06-21
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.